Scholars Central

EditorialPublished 30 Dec 2021

Editorial Note on Interferon and GvHD

Authors: Charles Martins

Journal of Immunology and Immunotherapy

Volume 5 · Issue 6 · Pages 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

For patients with hematological malignancies, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most successful and curative therapy option. Graft-versus-leukemia (GvL) effects and robust immunological reconstitution are two of the life-saving advantages of all-HSCT. The majority of patients, however, suffer Graft-vs-Host Disease (GvHD), which causes organ/tissue destruction in the skin, liver, and gastrointestinal system. As a result, substantial study on GvHD has been conducted, with IFNs being identified as a therapeutic target. Despite this, the pleiotropic nature of IFNs has hampered our efforts to achieve optimal GvHD management.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Immunology and Immunotherapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Immunology and Immunotherapy
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Charles Martins”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels